XTL Biopharmaceuticals Ltd.
XTLB · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $371 | $820 | $594 | $1,068 |
| Short-Term Investments | $772 | $900 | $992 | $1,271 |
| Receivables | $99 | $140 | $304 | $150 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $98 | $127 | $128 | $59 |
| Total Curr. Assets | $1,340 | $1,987 | $2,018 | $2,548 |
| Property Plant & Equip (Net) | $187 | $217 | $0 | $0 |
| Goodwill | $3,193 | $0 | $0 | $0 |
| Intangibles | $3,816 | $7,076 | $380 | $380 |
| Long-Term Investments | $14 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $7,210 | $7,293 | $380 | $380 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $8,550 | $9,280 | $2,398 | $2,928 |
| Liabilities | – | – | – | – |
| Payables | $196 | $554 | $165 | $223 |
| Short-Term Debt | $138 | $168 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $18 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,855 | $1,745 | $0 | $0 |
| Total Curr. Liab. | $2,207 | $2,467 | $165 | $223 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $219 | $331 | $0 | $0 |
| Other NC Liab. | $689 | $765 | $0 | $0 |
| Total NC Liab. | $908 | $1,096 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,115 | $3,563 | $165 | $223 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $23,138 | $23,138 | $14,120 | $14,120 |
| Retained Earnings | -$159,009 | -$158,766 | -$158,233 | -$157,761 |
| AOCI | $20 | $20 | $20 | $20 |
| Other Equity | $141,286 | $141,325 | $146,326 | $146,326 |
| Total Equity | $5,435 | $5,717 | $2,233 | $2,705 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $8,550 | $9,280 | $2,398 | $2,928 |
| Net Debt | -$233 | -$652 | -$594 | -$1,068 |